Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
scPharmaceuticals Inc (scPharmaceuticals) is a pharmaceutical company that specializes in the development and commercialization of innovative solutions to enhance outpatient care. The company lead product, FUROSCIX (furosemide injection), is a proprietary, subcutaneous diuretic formulation for treating congestion due to fluid overload in adults with certain classes of heart failure, featuring a fixed-dose auto-injector. scPharmaceuticals also conducts extensive research and development to develop innovative subcutaneous delivery systems, including investigational products like FUROSCIX and subcutaneous ceftriaxone, for enhanced outpatient care solutions. scPharmaceuticals is headquartered in Burlington, Massachusetts, the US.
Headquarters
United States of America
Address
Suite 203, 25 Mall Road, Burlington, Massachusetts, 01803
Website
www.scpharmaceuticals.com
Telephone
1 617 5170730
No of Employees
162
Industry
Pharmaceuticals and Healthcare
Revenue (2024)
$36.3M
Products and Services
| Products | Brands |
|---|---|
| Furoscix - (Furosemide Injection): Congestion due to Fluid Overload in Adults with Chronic Heart Failure (CHF) | FUROSCIX |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Ownership Changes | In October, the company was acquired by MannKind Corp, a biopharmaceutical company. |
| 2024 | Contracts/Agreements | In Jan, the company collaborated with Integrated Delivery Networks (IDNs) and hospital systems to expand the reach of FUROSCIX. |
| 2019 | Contracts/Agreements | In January, the company signed a development agreement with West Pharmaceutical Services for next-generation FUROSCIX on-body infusor. |
Competitor Comparison
| Key Parameters | scPharmaceuticals Inc | Johnson & Johnson | Merck & Co Inc | Pfizer Inc | AstraZeneca Plc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United Kingdom |
| City | Burlington | New Brunswick | Rahway | New York City | Cambridge |
| State/Province | Massachusetts | New Jersey | New Jersey | New York | Cambridgeshire |
| No. of Employees | 162 | 138,200 | 75,000 | 75,000 | 96,100 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jack A. Khattar | Chairman | Executive Board | 2017 | 63 |
| John H. Tucker | President; Chief Executive Officer | Executive Board | 2017 | 62 |
| Rachael Nokes | Chief Financial Officer | Senior Management | 2022 | 50 |
| John Mohr, Ph.D. | Senior Vice President - Clinical Development and Medical Affairs | Senior Management | - | - |
| Steve Parsons | Senior Vice President - Commercial | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer